Inhibition of miR-92b suppresses nonsmall cell lung cancer cells growth and motility by targeting RECK

Molecular and Cellular Biochemistry

Volumn 387, Issue 1-2, 2014, Pages 171-176

  Lei, Lin ^a   Huang, Yaping ^a   Gong, Wenrong ^b  

^a Xiangyang Central Hospital   (China)

^b Hu Bei University of Arts and Science   (China)

Author keywords

Growth; Invasion; Migration; miR 92; Nonsmall cell lung cancer

Indexed keywords

BASE SEQUENCE; BINDING SITES; CARCINOMA, NON-SMALL-CELL LUNG; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; GENE EXPRESSION; GENE EXPRESSION REGULATION, NEOPLASTIC; GPI-LINKED PROTEINS; HEK293 CELLS; HUMANS; LUNG NEOPLASMS; MICRORNAS; RNA INTERFERENCE;

EID: 84893862369     PISSN: 03008177     EISSN: 15734919     Source Type: Journal    
DOI: 10.1007/s11010-013-1882-5     Document Type: Article

References (24)

1. Siegel R, Naishadham D, Jemal A (2012) Cancer statistics, 2012. CA Cancer J Clin 62:10-29
2. Ramalingam SS, Owonikoko TK, Khuri FR (2011) Lung cancer: new biological insights and recent therapeutic advances. CA Cancer J Clin 61:91-112
3. Yates LA, Norbury CJ, Gilbert RJ (2013) The long and short of microRNA. Cell 153:516-519
4. Fendler A, Jung K (2013) microRNAs as new diagnostic and prognostic biomarkers in urological tumors. Crit Rev Oncog 18:289-302
5. Lewis BP, Burge CB, Bartel DP (2005) Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell 120:15-20 (Pubitemid 40094598)
6. Schepeler T (2013) Emerging roles of microRNAs in the Wnt signaling network. Crit Rev Oncog 18:357-371
7. Ke Y, Zhao W, Xiong J, Cao R (2013) Downregulation of miR-16 promotes growth and motility by targeting HDGF in non-small cell lung cancer cells. FEBS Lett. doi: 10.1016/j.febslet.2013.08.010
8. Zhang N, Wei X, Xu L (2013) miR-150 promotes the proliferation of lung cancer cells by targeting P53. FEBS Lett 587:2346-2351
9. Ma Q, Jiang Q, Pu Q, Zhang X, Yang W, Wang Y, Ye S, Wu S, Zhong G, Ren J, Zhang Y, Liu L, Zhu W (2013) microRNA-143 inhibits migration and invasion of human non-small-cell lung cancer and its relative mechanism. Int J Biol Sci 9:680-692
10. Guo F, Tian J, Lin Y, Jin Y, Wang L, Cui M (2013) Serum microRNA-92 expression in patients with ovarian epithelial carcinoma. J Int Med Res. doi: 10.1177/0300060513487652
11. Tsuchida A, Ohno S, Wu W, Borjigin N, Fujita K, Aoki T, Ueda S, Takanashi M, Kuroda M (2011) miR-92 is a key oncogenic component of the miR-17-92 cluster in colon cancer. Cancer Sci 102:2264-2271
12. Haug BH, Henriksen JR, Buechner J, Geerts D, Tomte E, Kogner P, Martinsson T, Flaegstad T, Sveinbjornsson B, Einvik C (2011) MYCN-regulated miRNA-92 inhibits secretion of the tumor suppressor DICKKOPF-3 (DKK3) in neuroblastoma. Carcinogenesis 32:1005-1012
13. Vosa U, Vooder T, Kolde R, Fischer K, Valk K, Tonisson N, Roosipuu R, Vilo J, Metspalu A, Annilo T (2011) Identification of miR-374a as a prognostic marker for survival in patients with early-stage nonsmall cell lung cancer. Genes Chromosomes Cancer 50:812-822
14. Wang R, Wang ZX, Yang JS, Pan X, De W, Chen LB (2011) microRNA-451 functions as a tumor suppressor in human non-small cell lung cancer by targeting ras-related protein 14 (RAB14). Oncogene 30:2644-2658
15. Sengupta S, Nie J, Wagner RJ, Yang C, Stewart R, Thomson JA (2009) microRNA-92b controls the G1/S checkpoint gene p57 in human embryonic stem cells. Stem Cells 27:1524-1528
16. Dalmasso G, Nguyen HT, Yan Y, Laroui H, Charania MA, Obertone TS, Sitaraman SV, Merlin D (2011) microRNA-92b regulates expression of the oligopeptide transporter PepT1 in intestinal epithelial cells. Am J Physiol Gastrointest Liver Physiol 300:G52-G59
17. Wang K, Wang X, Zou J, Zhang A, Wan Y, Pu P, Song Z, Qian C, Chen Y, Yang S, Wang Y (2013) miR-92b controls glioma proliferation and invasion through regulating Wnt/beta-catenin signaling via Nemo-like kinase. Neuro Oncol 15:578-588
18. Li N, Tang B, Zhu ED, Li BS, Zhuang Y, Yu S, Lu DS, Zou QM, Xiao B, Mao XH (2012) Increased miR-222 in H. pylori-associated gastric cancer correlated with tumor progression by promoting cancer cell proliferation and targeting RECK. FEBS Lett 586:722-728
19. Clark JC, Thomas DM, Choong PF, Dass CR (2007) RECK - a newly discovered inhibitor of metastasis with prognostic significance in multiple forms of cancer. Cancer Metastasis Rev 26:675-683 (Pubitemid 350115122)
20. Lu XX, Zhang SM, Fang Y, Wang ZT, Xie JJ, Zhan Q, Deng XX, Chen H, Jin JB, Peng CH, Li HW, Shen BY (2013) Clinical significance of RECK promoter methylation in pancreatic ductal adenocarcinoma. Tumor Biol. doi: 10.1007/s13277-013-0903-z
21. Zhang Y, Cheng S, Zhang G, Ma W, Liu Y, Zhao R, Zhang Q, Pang D (2012) Low expression of RECK indicates a shorter survival for patients with invasive breast cancer. Cancer Sci 103:1084-1089
22. Du YY, Dai DQ, Yang Z (2010) Role of RECK methylation in gastric cancer and its clinical significance. World J Gastroenterol 16:904-908
23. Wang N, Zhang CQ, He JH, Duan XF, Wang YY, Ji X, Zang WQ, Li M, Ma YY, Wang T, Zhao GQ (2013) miR-21 down-regulation suppresses cell growth, invasion and induces cell apoptosis by targeting FASL, TIMP3, and RECK genes in esophageal carcinoma. Dig Dis Sci 58:1863-1870
24. Xin C, Buhe B, Hongting L, Chuanmin Y, Xiwei H, Hong Z, Lulu H, Qian D, Renjie W (2013) microRNA-15a promotes neuroblastoma migration by targeting reversion-inducing cysteine-rich protein with Kazal motifs (RECK) and regulating matrix metalloproteinase-9 expression. FEBS J 280:855-866